Literature DB >> 26432177

[Facial palsy sequel and botulinum toxin].

L Benichou1, D Labbe2, C Le Louarn3, P Guerreschi4.   

Abstract

Medical treatment of facial paralysis sequel is an essential part of the overall management of this pathology. The use of botulinum toxin has revolutionized results in greatly improving facial symmetry. The toxin can be used either the healthy side of the face by treating the compensatory hyperactivity of non-paralyzed side of the face or the paralyzed side (in the spastic forms) to treat synkinesis and spasms of the face on the pathologic side. This treatment course will be complemented by the rest of the therapeutic, i.e. rehabilitation and surgical treatment.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Co-contraction; Facial paralysis; Hyperactivity; Hyperactivité; Paralysie faciale; Spasm; Spasme; Syncinésie; Synkinesis; Toxine botulique; Traitement; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26432177     DOI: 10.1016/j.anplas.2015.07.011

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  2 in total

Review 1.  Use of Botulinum Toxin in Orofacial Clinical Practice.

Authors:  Maria-Angeles Serrera-Figallo; Gonzalo Ruiz-de-León-Hernández; Daniel Torres-Lagares; Alejandra Castro-Araya; Omar Torres-Ferrerosa; Esther Hernández-Pacheco; Jose-Luis Gutierrez-Perez
Journal:  Toxins (Basel)       Date:  2020-02-11       Impact factor: 4.546

Review 2.  Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.

Authors:  Carla de Sanctis Pecora; Danielle Shitara
Journal:  Toxins (Basel)       Date:  2021-02-18       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.